Lataa...
Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)
OBJECTIVES: Alterations in dopamine neurotransmission underlie some of the clinical features of Huntington’s disease (HD) and as such are a target for therapeutic intervention, especially for the treatment of chorea and some behavioural problems. However, justification for such an intervention is ma...
Tallennettuna:
| Julkaisussa: | J Neurol Neurosurg Psychiatry |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7279191/ https://ncbi.nlm.nih.gov/pubmed/32229581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2019-322038 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|